Leading Pharmaceutical and Biopharmaceutical Company | Pfizer

 

Your Health

3 Lifestyle Changes for Better Liver Health

Research shows that certain risk factors may increase the likelihood of developing NASH. While the prospect of developing NASH may be concerning, a number of lifestyle changes may help lower the risk of developing the condition.

Learn steps to take to help retain liver health
Your Health

Changing the trajectory of cancer takes focus at scale

Hear more from our leadership about our presence at ESMO 2018.

Read More
Our Purpose

Partnerships in Family Planning

At the 2018 International Conference on Family Planning, we’re featuring key partnerships that work to support family health.

Experience Our Integrated Services in a VR Film
Your Health

Creating Meaningful Dialogue with the Rheumatoid Arthritis Community

On October 12th, the rheumatology community will come together in recognition of World Arthritis Day.

Read More

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search
Our Science

Two Promising Neuroscience Startups Awarded “Golden Tickets”

In June 2018, Pfizer Kendall Square opened a call for interested U.S. startup companies focused on neuroscience to submit non-confidential proposals for a Pfizer-sponsored LabCentral “Golden Ticket.”

Learn More
News

Important Update on EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors

Extended Expiration Dates for Select Lots of EpiPen® 0.3 mg Auto-Injectors and Its Authorized Generic

View the update
Latest news
U.S. FDA Approves LORBRENA® (lorlatinib) for...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved LORBRENA® [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK)...

Read more